Position in PMI
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$9
New position
Shares Held
9
first reported quarter
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Medical Devices
Healthcare · as of Mar 31, 2026MAI Capital Management holds $121,852,692 across 82 Medical Devices names. PMI ranks #81 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
|
417,847 | $42,900,351 | |
| 2 | SYK |
Stryker Corp
|
113,754 | $37,378,426 | |
| 3 | BSX |
Boston Scientific Corp
|
330,209 | $20,720,614 | |
| 4 | MDT |
Medtronic plc
|
122,922 | $10,651,191 | |
| 5 | EW |
Edwards Lifesciences Corp
|
88,480 | $7,085,478 | |
| 6 | PODD |
Insulet Corp
|
2,792 | $585,873 | |
| 7 | STE |
STERIS plc
|
2,219 | $490,687 | |
| 8 | GEHC |
GE HealthCare Technologies Inc.
|
6,772 | $482,030 |
All Filings in PMI
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $9 | 9 | Shares | Sole | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||